RxDoctor Payments Data

Hema Sundaram, MD

Dermatology · Fairfax, VANPI 1417048133

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $150,513 of the $181,255 with a category attached, or 83.0%. IBSA Institut Biochimique SA accounts for 64.4% of it on its own, with 7 other manufacturers making up the rest. Among dermatology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$181,255in general payments, 2019–2025

Across 59 payments — averaging $3072.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • IBSA Institut Biochimique SA$117K
  • AbbVie$47K
  • Galderma Laboratories, L.p.$6K
  • Krystal Biotech Inc$5K
  • Musculoskeletal Transplant Foundation Inc.$5K
  • Almirall LLC$930
  • plus $298 from 2 others
$58,703in research payments, 2019–2025

Across 12 payments — averaging $4891.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Galderma Laboratories, L.p.$59K

What the payments were for

  • Consulting fees$150,51383%
  • Speaking & faculty fees$9301%
  • Grants$25,00014%
  • Travel & lodging$4,2582%
  • Food & beverage$2440%
  • Education$3100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$181,255 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia

Medicare billing

Part B allowed, 2024
$59,648
Medicare patients
56
Services billed
654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →